Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia

Infection, Genetics and Evolution

Volumn 46, Issue , 2016, Pages 256-268

  Nikolopoulos, Georgios K ^a,b   Kostaki, Evangelia Georgia ^c   Paraskevis, Dimitrios ^c  

^a Hellenic Centre for Diseases Control and Prevention   (Greece)

^b Transmission Reduction Intervention Project Athens site   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Drug injecting; HIV; Molecular epidemiology; PWID; Subtypes

Indexed keywords

AFGHANISTAN; ASIA; BANGLADESH; DRUG USE; EPIDEMIC; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; IRAN; MISCELLANEOUS NAMED GROUPS; MOLECULAR EPIDEMIOLOGY; NEPAL; NONHUMAN; PAKISTAN; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; REVIEW; USSR; VIRUS TRANSMISSION; CLASSIFICATION; COMPLICATION; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; SUBSTANCE ABUSE; VIROLOGY;

ASIA; EUROPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR EPIDEMIOLOGY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 85000634253     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.06.017     Document Type: Review

References (253)

1. Abdul-Quader, A.S., Feelemyer, J., Modi, S., Stein, E.S., Briceno, A., Semaan, S., Horvath, T., Kennedy, G.E., Des Jarlais, D.C., Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 17 (2013), 2878–2892, 10.1007/s10461-013-0593-y.
2. Abecasis, A.B., Deforche, K., Bacheler, L.T., McKenna, P., Carvalho, A.P., Gomes, P., Vandamme, A.-M., Camacho, R.J., Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG. Antivir. Ther. 11 (2006), 581–589.
3. Abecasis, A.B., Wensing, A.M.J., Paraskevis, D., Vercauteren, J., Theys, K., Van de Vijver, D.A.M.C., Albert, J., Asjö, B., Balotta, C., Beshkov, D., Camacho, R.J., Clotet, B., De Gascun, C., Griskevicius, A., Grossman, Z., Hamouda, O., Horban, A., Kolupajeva, T., Korn, K., Kostrikis, L.G., Kücherer, C., Liitsola, K., Linka, M., Nielsen, C., Otelea, D., Paredes, R., Poljak, M., Puchhammer-Stöckl, E., Schmit, J.-C., Sönnerborg, A., Stanekova, D., Stanojevic, M., Struck, D., Boucher, C.A.B., Vandamme, A.-M., HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology, 10, 2013, 7, 10.1186/1742-4690-10-7.
4. Adojaan, M., Kivisild, T., Männik, A., Krispin, T., Ustina, V., Zilmer, K., Liebert, E., Jaroslavtsev, N., Priimägi, L., Tefanova, V., Schmidt, J., Krohn, K., Villems, R., Salminen, M., Ustav, M., Predominance of a rare type of HIV-1 in Estonia. J. Acquir. Immune Defic. Syndr. 39 (2005), 598–605.
5. Altaf, A., Saleem, N., Abbas, S., Muzaffar, R., High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. J. Pak. Med. Assoc. 59 (2009), 136–140.
6. Angelis, K., Albert, J., Mamais, I., Magiorkinis, G., Hatzakis, A., Hamouda, O., Struck, D., Vercauteren, J., Wensing, A.M.J., Alexiev, I., Åsjö, B., Balotta, C., Camacho, R.J., Coughlan, S., Griskevicius, A., Grossman, Z., Horban, A., Kostrikis, L.G., Lepej, S., Liitsola, K., Linka, M., Nielsen, C., Otelea, D., Paredes, R., Poljak, M., Puchhammer-Stöckl, E., Schmit, J.-C., Sönnerborg, A., Staneková, D., Stanojevic, M., Boucher, C.A.B., Kaplan, L., Vandamme, A.-M., Paraskevis, D., Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia. J. Infect. Dis. 211 (2015), 1735–1744, 10.1093/infdis/jiu666.
7. Archibald, C.P., Shaw, S.Y., Emmanuel, F., Otho, S., Reza, T., Altaf, A., Musa, N., Thompson, L.H., Blanchard, J.F., Geographical and temporal variation of injection drug users in Pakistan. Sex. Transm. Infect. 89:Suppl. 2 (2013), ii18–ii28, 10.1136/sextrans-2012-050775.
8. Armstrong, G., Medhi, G.K., Mahanta, J., Paranjape, R.S., Kermode, M., Undiagnosed HIV among people who inject drugs in Manipur, India. AIDS Care 27 (2015), 288–292, 10.1080/09540121.2014.972322.
9. Aspinall, E.J., Nambiar, D., Goldberg, D.J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J.S., Hellard, M.E., Hutchinson, S.J., Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int. J. Epidemiol. 43 (2014), 235–248, 10.1093/ije/dyt243.
10. Avi, R., Huik, K., Pauskar, M., Ustina, V., Karki, T., Krispin, T., Ainsalu, K., Paap, P., Schmidt, J., Nikitina, N., Lutsar, I., Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. Scand. J. Infect. Dis. 43 (2011), 122–128, 10.3109/00365548.2010.526956.
11. Azim, T., Bogaerts, J., Yirrell, D.L., Banerjea, A.C., Sarker, M.S., Ahmed, G., Amin, M.M.M., Rahman, A.S.M.M., Hussain, A.M.Z., Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes. AIDS 16 (2002), 121–123.
12. Baesi, K., Moallemi, S., Farrokhi, M., Alinaghi, S.A.S., Truong, H.-H.M., Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013. PLoS One, 9, 2014, e105098, 10.1371/journal.pone.0105098.
13. Baeten, J.M., Chohan, B., Lavreys, L., Chohan, V., McClelland, R.S., Certain, L., Mandaliya, K., Jaoko, W., Overbaugh, J., HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 195 (2007), 1177–1180, 10.1086/512682.
14. Balode, D., Ferdats, A., Dievberna, I., Viksna, L., Rozentale, B., Kolupajeva, T., Konicheva, V., Leitner, T., Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups. AIDS Res. Hum. Retrovir. 20 (2004), 245–249, 10.1089/088922204773004978.
15. Balode, D., Skar, H., Mild, M., Kolupajeva, T., Ferdats, A., Rozentale, B., Leitner, T., Albert, J., Phylogenetic analysis of the Latvian HIV-1 epidemic. AIDS Res. Hum. Retrovir. 28 (2012), 928–932, 10.1089/AID.2011.0310.
16. Bannister, W.P., Ruiz, L., Loveday, C., Vella, S., Zilmer, K., Kjaer, J., Knysz, B., Phillips, A.N., Mocroft, A., HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir. Ther. 11 (2006), 707–715.
17. Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L., Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (1983), 868–871.
18. Bártolo, I., Rocha, C., Bartolomeu, J., Gama, A., Marcelino, R., Fonseca, M., Mendes, A., Epalanga, M., Silva, P.C., Taveira, N., Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic. Infect. Genet. Evol. 9 (2009), 672–682, 10.1016/j.meegid.2008.05.003.
19. Bártolo, I., Abecasis, A.B., Borrego, P., Barroso, H., McCutchan, F., Gomes, P., Camacho, R., Taveira, N., Origin and epidemiological history of HIV-1 CRF14_BG. PLoS One, 6, 2011, e24130, 10.1371/journal.pone.0024130.
20. Baryshev, P.B., Bogachev, V.V., Gashnikova, N.M., Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia. Arch. Virol. 157 (2012), 2335–2341, 10.1007/s00705-012-1442-4.
21. Baryshev, P.B., Bogachev, V.V., Gashnikova, N.M., HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia. AIDS Res. Hum. Retrovir. 30 (2014), 592–597, 10.1089/aid.2013.0196.
22. Beyrer, C., Vancott, T.C., Peng, N.K., Artenstein, A., Duriasamy, G., Nagaratnam, M., Saw, T.L., Hegerich, P.A., Loomis-Price, L.D., Hallberg, P.L., Ettore, C.A., Nelson, K.E., HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992–1996. AIDS Res. Hum. Retrovir. 14 (1998), 1687–1691.
23. Beyrer, C., Razak, M.H., Lisam, K., Chen, J., Lui, W., Yu, X.F., Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 14 (2000), 75–83.
24. Beyrer, C., Patel, Z., Stachowiak, J.A., Tishkova, F.K., Stibich, M.A., Eyzaguirre, L.M., Carr, J.K., Mogilnii, V., Peryshkina, A., Latypov, A., Strathdee, S.A., Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. AIDS Res. Hum. Retrovir. 25 (2009), 853–860, 10.1089/aid.2008.0206.
25. Bhanja, P., Sengupta, S., Singh, N.Y., Sarkar, K., Bhattacharya, S.K., Chakrabarti, S., Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: evidence for intersubtype recombination. Virus Res. 114 (2005), 149–153, 10.1016/j.virusres.2005.06.008.
26. Bobkov, A., Cheingsong-Popov, R., Garaev, M., Rzhaninova, A., Kaleebu, P., Beddows, S., Bachmann, M.H., Mullins, J.I., Louwagie, J., Janssens, W., Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS 8 (1994), 1649–1655.
27. Bobkov, A., Kazennova, E., Khanina, T., Bobkova, M., Selimova, L., Kravchenko, A., Pokrovsky, V., Weber, J., An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk. AIDS Res. Hum. Retrovir. 17 (2001), 257–261, 10.1089/088922201750063188.
28. Bobkov, A.F., Kazennova, E.V., Selimova, L.M., Khanina, T.A., Ryabov, G.S., Bobkova, M.R., Sukhanova, A.L., Kravchenko, A.V., Ladnaya, N.N., Weber, J.N., Pokrovsky, V.V., Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J. Med. Virol. 74 (2004), 191–196, 10.1002/jmv.20177.
29. Bobkov, A.F., Kazennova, E.V., Sukhanova, A.L., Bobkova, M.R., Pokrovsky, V.V., Zeman, V.V., Kovtunenko, N.G., Erasilova, I.B., An HIV type 1 subtype A outbreak among injecting drug users in Kazakhstan. AIDS Res. Hum. Retrovir. 20 (2004), 1134–1136, 10.1089/aid.2004.20.1134.
30. Bobkova, M., Current status of HIV-1 diversity and drug resistance monitoring in the former USSR. AIDS Rev. 15 (2013), 204–212.
31. Bontell, I., Sarker, M.S., Rahman, M., Afrad, M.H., Sönnerborg, A., Azim, T., Molecular dating of HIV-1 subtype C from Bangladesh. PLoS One, 8, 2013, e79193, 10.1371/journal.pone.0079193.
32. Braitstein, P., Justice, A., Bangsberg, D.R., Yip, B., Alfonso, V., Schechter, M.T., Hogg, R.S., Montaner, J.S.G., Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 20 (2006), 323–331, 10.1097/01.aids.0000198091.70325.f4.
33. Brenner, B., Turner, D., Oliveira, M., Moisi, D., Detorio, M., Carobene, M., Marlink, R.G., Schapiro, J., Roger, M., Wainberg, M.A., A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 17 (2003), F1–F5, 10.1097/01.aids.0000042957.95433.6c.
34. Brown, T.M., Robbins, K.E., Sinniah, M., Saraswathy, T.S., Lee, V., Hooi, L.S., Vijayamalar, B., Luo, C.C., Ou, C.Y., Rapier, J., Schochetman, G., Kalish, M.L., HIV type 1 subtypes in Malaysia include B, C, and E. AIDS Res. Hum. Retrovir. 12 (1996), 1655–1657.
35. Campbell-Yesufu, O.T., Gandhi, R.T., Update on human immunodeficiency virus (HIV)-2 infection. Clin. Infect. Dis. 52 (2011), 780–787, 10.1093/cid/ciq248.
36. Caplinskas, S., Loukachov, V.V., Gasich, E.L., Gilyazova, A.V., Caplinskiene, I., Lukashov, V.V., Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania. AIDS Res. Hum. Retrovir. 29 (2013), 732–737, 10.1089/AID.2012.0312.
37. Carr, J.K., Nadai, Y., Eyzaguirre, L., Saad, M.D., Khakimov, M.M., Yakubov, S.K., Birx, D.L., Graham, R.R., Wolfe, N.D., Earhart, K.C., Sanchez, J.L., Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J. Acquir. Immune Defic. Syndr. 39 (2005), 570–575.
38. Carvalho, A., Costa, P., Triunfante, V., Branca, F., Rodrigues, F., Santos, C.L., Correia-Neves, M., Saraiva, M., Lecour, H., Castro, A.G., Pedrosa, J., Osório, N.S., Analysis of a local HIV-1 epidemic in portugal highlights established transmission of non-B and non-G subtypes. J. Clin. Microbiol. 53 (2015), 1506–1514, 10.1128/JCM.03611-14.
39. Casado, C., Urtasun, I., Saragosti, S., Chaix, M.L., de Rossi, A., Cattelan, A.M., Dietrich, U., López-Galíndez, C., Different distribution of HIV type 1 genetic variants in European patients with distinct risk practices. AIDS Res. Hum. Retrovir. 16 (2000), 299–304, 10.1089/088922200309403.
40. Centers for Disease Control, Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men–New York City and California. MMWR Morb. Mortal. Wkly Rep. 30 (1981), 305–308.
41. Centers for Disease Control, Pneumocystis pneumonia–Los Angeles. MMWR Morb. Mortal. Wkly Rep. 30 (1981), 250–252.
42. Centers for Disease Control, Update on acquired immune deficiency syndrome (AIDS)–United States. MMWR Morb. Mortal. Wkly Rep. 31:507–8 (1982), 513–514.
43. Centers for Disease Control, A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR. Morb. Mortal. Wkly. Rep. 31 (1982), 305–307.
44. Chabadová, Z., Habeková, M., Truska, P., Drobková, T., Mojzesová, M., Staneková, D., Distribution of HIV-1 subtypes circulating in Slovakia (2009-2012). Acta Virol. 58 (2014), 317–324.
45. Charneau, P., Borman, A.M., Quillent, C., Guétard, D., Chamaret, S., Cohen, J., Rémy, G., Montagnier, L., Clavel, F., Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 205 (1994), 247–253, 10.1006/viro.1994.1640.
46. Chen, J.H.K., Wong, K.H., Li, P., Chan, K.C., Lee, M.P., Lam, H.Y., Cheng, V.C.C., Yuen, K.Y., Yam, W.C., Molecular epidemiological study of HIV-1 CRF01_AE transmission in Hong Kong. J. Acquir. Immune Defic. Syndr. 51 (2009), 530–535, 10.1097/QAI.0b013e3181aac516.
47. Chen, Y.-J., Huang, Y.-H., Chuang, S.-Y., Kao, D.Y.-T., Lan, Y.-C., Yang, J.-Y., Chen, Y.-M.A., Molecular epidemiology of HIV-1 subtype B, CRF01_AE, and CRF07_BC infection among injection drug users in Taiwan. J. Acquir. Immune Defic. Syndr. 53 (2010), 425–439, 10.1097/QAI.0b013e3181ccba1a.
48. Chen, Y.-J., Lee, C.-M., Chen, M., Chuang, S.-Y., Liu, H.-F., Wong, W.-W., Lin, Y.-H., Tsai, H.-C., Wang, J.-H., Chen, Y.-M.A., Molecular epidemiology of HIV-1 infection in Taiwan from 2005 to 2008: further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection. J. Acquir. Immune Defic. Syndr. 59 (2012), 438–446, 10.1097/QAI.0b013e3182454ea3.
49. Chow, W.Z., Ong, L.Y., Razak, S.H., Lee, Y.M., Ng, K.T., Yong, Y.K., Azmel, A., Takebe, Y., Al-Darraji, H.A.A., Kamarulzaman, A., Tee, K.K., Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters. PLoS One, 8, 2013, e62560, 10.1371/journal.pone.0062560.
50. Chow, W.Z., Takebe, Y., Syafina, N.E., Prakasa, M.S., Chan, K.G., Al-Darraji, H.A.A., Koh, C., Kamarulzaman, A., Tee, K.K., A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia. PLoS One, 9, 2014, e85250, 10.1371/journal.pone.0085250.
51. Ciccozzi, M., Montieri, S., Salemi, M., De Oliveira, T., Dorrucci, M., Sinicco, A., De Luca, A., Giuliani, M., Balotta, C., Rezza, G., An outbreak of HIV-1 subtype G among Italian injecting drug users. AIDS 21 (2007), 1213–1215, 10.1097/QAD.0b013e32813aee1a.
52. Clavel, F., Guétard, D., Brun-Vézinet, F., Chamaret, S., Rey, M.A., Santos-Ferreira, M.O., Laurent, A.G., Dauguet, C., Katlama, C., Rouzioux, C., Klatzmann, D., Champalimaud, J., Montagner, L., Isolation of a new human retrovirus from West African patients with AIDS. Science 233 (1986), 343–346.
53. Cohen, M.S., Chen, Y.Q., McCauley, M., Gamble, T., Hosseinipour, M.C., Kumarasamy, N., Hakim, J.G., Kumwenda, J., Grinsztejn, B., Pilotto, J.H.S., Godbole, S.V., Mehendale, S., Chariyalertsak, S., Santos, B.R., Mayer, K.H., Hoffman, I.F., Eshleman, S.H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L.A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T.E., Nielsen-Saines, K., Celentano, D., Essex, M., Fleming, T.R., Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365 (2011), 493–505, 10.1056/NEJMoa1105243.
54. Cohen, M.S., Shaw, G.M., McMichael, A.J., Haynes, B.F., Acute HIV-1 Infection. N. Engl. J. Med. 364 (2011), 1943–1954, 10.1056/NEJMra1011874.
55. D'arc, M., Ayouba, A., Esteban, A., Learn, G.H., Boué, V., Liegeois, F., Etienne, L., Tagg, N., Leendertz, F.H., Boesch, C., Madinda, N.F., Robbins, M.M., Gray, M., Cournil, A., Ooms, M., Letko, M., Simon, V.A., Sharp, P.M., Hahn, B.H., Delaporte, E., Mpoudi Ngole, E., Peeters, M., Origin of the HIV-1 group O epidemic in western lowland gorillas. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E1343–E1352, 10.1073/pnas.1502022112.
56. Delgado, E., Thomson, M.M., Villahermosa, M.L., Sierra, M., Ocampo, A., Miralles, C., Rodríguez-Pérez, R., Diz-Aren, J., Ojea-de Castro, R., Losada, E., Cuevas, M.T., Vázquez-de Parga, E., Carmona, R., Pérez-Alvarez, L., Medrano, L., Cuevas, L., Taboada, J.A., Nájera, R., Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J. Acquir. Immune Defic. Syndr. 29 (2002), 536–543.
57. Deng, X., Liu, H., Shao, Y., Rayner, S., Yang, R., The epidemic origin and molecular properties of B’: a founder strain of the HIV-1 transmission in Asia. AIDS 22 (2008), 1851–1858, 10.1097/QAD.0b013e32830f4c62.
58. Des Jarlais, D.C., Arasteh, K., Friedman, S.R., HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst. Use Misuse 46 (2011), 131–139, 10.3109/10826084.2011.521456.
59. Des Jarlais, D.C., Feelemyer, J.P., Modi, S.N., Abdul-Quader, A., Hagan, H., High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health, 13, 2013, 53, 10.1186/1471-2458-13-53.
60. Díez-Fuertes, F., Cabello, M., Thomson, M.M., Bayesian phylogeographic analyses clarify the origin of the HIV-1 subtype A variant circulating in former Soviet Union's countries. Infect. Genet. Evol. 33 (2015), 197–205, 10.1016/j.meegid.2015.05.003.
61. Duque, V., Holguín, A., Silvestre, M., González-Lahoz, J., Soriano, V., Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. Clin. Microbiol. Infect. 9 (2003), 422–425.
62. Ekouevi, D.K., Tchounga, B.K., Coffie, P.A., Tegbe, J., Anderson, A.M., Gottlieb, G.S., Vitoria, M., Dabis, F., Eholie, S.P., Antiretroviral therapy response among HIV-2 infected patients: a systematic review. BMC Infect. Dis., 14, 2014, 461, 10.1186/1471-2334-14-461.
63. Eremin, V.F., Gasich, E.L., Sasinovich, S.V., A new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother. AIDS Res. Hum. Retrovir. 27 (2011), 1323–1326, 10.1089/AID.2011.0112.
64. Esteves, A., Parreira, R., Venenno, T., Franco, M., Piedade, J., Germano De Sousa, J., Canas-Ferreira, W.F., Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. AIDS Res. Hum. Retrovir. 18 (2002), 313–325, 10.1089/088922202753519089.
65. Esteves, A., Parreira, R., Piedade, J., Venenno, T., Franco, M., Germano de Sousa, J., Patrício, L., Brum, P., Costa, A., Canas-Ferreira, W.F., Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res. Hum. Retroviruses 19 (2003), 511–517, 10.1089/088922203766774568.
66. European Centre for Disease Prevention and Control (ECDC)/World Health Organization (WHO), HIV/AIDS Surveilance in Europe. 2014 (Stockholm, Sweden).
67. Eyzaguirre, L.M., Erasilova, I.B., Nadai, Y., Saad, M.D., Kovtunenko, N.G., Gomatos, P.J., Zeman, V.V., Botros, B.A., Sanchez, J.L., Birx, D.L., Earhart, K.C., Carr, J.K., Genetic characterization of HIV-1 strains circulating in Kazakhstan. J. Acquir. Immune Defic. Syndr. 46 (2007), 19–23, 10.1097/QAI.0b013e318073c620.
68. Faria, N.R., Rambaut, A., Suchard, M.A., Baele, G., Bedford, T., Ward, M.J., Tatem, A.J., Sousa, J.D., Arinaminpathy, N., Pepin, J., Posada, D., Peeters, M., Pybus, O.G., Lemey, P., The early spread and epidemic ignition of HIV-1 in human populations. Science 346 (2014), 56–61, 10.1126/science.1256739.
69. Ferdats, A., Konicheva, V., Dievberna, I., Lilja, E., Albert, J., An HIV type 1 subtype A outbreak among injecting drug users in Latvia. AIDS Res. Hum. Retrovir. 15 (1999), 1487–1490, 10.1089/088922299310007.
70. Friedman, S.R., Rossi, D., Braine, N., Theorizing “Big Events” as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. Int. J. Drug Policy 20 (2009), 283–291, 10.1016/j.drugpo.2008.10.006.
71. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., Markham, P., Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224 (1984), 500–503.
72. Gao, F., Yue, L., White, A.T., Pappas, P.G., Barchue, J., Hanson, A.P., Greene, B.M., Sharp, P.M., Shaw, G.M., Hahn, B.H., Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 358 (1992), 495–499, 10.1038/358495a0.
73. Gao, F., Bailes, E., Robertson, D.L., Chen, Y., Rodenburg, C.M., Michael, S.F., Cummins, L.B., Arthur, L.O., Peeters, M., Shaw, G.M., Sharp, P.M., Hahn, B.H., Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397 (1999), 436–441, 10.1038/17130.
74. Giannou, F.K., Tsiara, C.G., Nikolopoulos, G.K., Talias, M., Benetou, V., Kantzanou, M., Bonovas, S., Hatzakis, A., Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev. Pharmacoecon. Outcomes Res., 2015, 1–11, 10.1586/14737167.2016.1102635.
75. Glauser, M.P., Francioli, P., Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe. Eur. J. Clin. Microbiol. 3 (1984), 55–58.
76. Goswami, P., Medhi, G.K., Armstrong, G., Setia, M.S., Mathew, S., Thongamba, G., Ramakrishnan, L., George, B., Singh, R.K., Paranjape, R.S., Mahanta, J., An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India. Int. J. Drug Policy 25 (2014), 853–864, 10.1016/j.drugpo.2014.04.016.
77. Gottlieb, M.S., Schroff, R., Schanker, H.M., Weisman, J.D., Fan, P.T., Wolf, R.A., Saxon, A., Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305 (1981), 1425–1431, 10.1056/NEJM198112103052401.
78. Graf, M., Shao, Y., Zhao, Q., Seidl, T., Köstler, J., Wolf, H., Wagner, R., Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B’-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res. Hum. Retrovir. 14 (1998), 285–288.
79. Grant, R.M., Lama, J.R., Anderson, P.L., McMahan, V., Liu, A.Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J.V., Ramirez-Cardich, M.E., Montoya-Herrera, O., Fernández, T., Veloso, V.G., Buchbinder, S.P., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Mayer, K.H., Kallás, E.G., Amico, K.R., Mulligan, K., Bushman, L.R., Hance, R.J., Ganoza, C., Defechereux, P., Postle, B., Wang, F., McConnell, J.J., Zheng, J.-H., Lee, J., Rooney, J.F., Jaffe, H.S., Martinez, A.I., Burns, D.N., Glidden, D.V., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363 (2010), 2587–2599, 10.1056/NEJMoa1011205.
80. Gürtler, L.G., Hauser, P.H., Eberle, J., von Brunn, A., Knapp, S., Zekeng, L., Tsague, J.M., Kaptue, L., A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68 (1994), 1581–1585.
81. Habekova, M., Takacova, M., Lysy, J., Mokras, M., Camacho, R., Truska, P., Stanekova, D., Genetic subtypes of HIV type 1 circulating in Slovakia. AIDS Res. Hum. Retrovir. 26 (2010), 1103–1107, 10.1089/aid.2009.0220.
82. Han, X., An, M., Zhao, B., Duan, S., Yang, S., Xu, J., Zhang, M., McGoogan, J.M., Takebe, Y., Shang, H., High prevalence of HIV-1 intersubtype B’/C recombinants among injecting drug users in Dehong, China. PLoS One, 8, 2013, e65337, 10.1371/journal.pone.0065337.
83. Han, J., Liu, S., Guo, W., Bao, Z., Wang, X., Li, L., Liu, Y., Zhuang, D., Li, H., Jia, L., Gui, T., Sui, H., Li, T., Li, J., Development of an HIV-1 subtype panel in China: isolation and characterization of 30 HIV-1 primary strains circulating in China. PLoS One, 10, 2015, e0127696, 10.1371/journal.pone.0127696.
84. Harris, B., von Truchsess, I., Schätzl, H.M., Devare, S.G., Hackett, J., Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. AIDS Res. Hum. Retrovir. 21 (2005), 654–660, 10.1089/aid.2005.21.654.
85. Hatzakis, A., Sypsa, V., Paraskevis, D., Nikolopoulos, G., Tsiara, C., Micha, K., Panopoulos, A., Malliori, M., Psichogiou, M., Pharris, A., Wiessing, L., van de Laar, M., Donoghoe, M., Heckathorn, D.D., Friedman, S.R., Des Jarlais, D.C., Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction 110 (2015), 1453–1467, 10.1111/add.12999.
86. He, X., Xing, H., Ruan, Y., Hong, K., Cheng, C., Hu, Y., Xin, R., Wei, J., Feng, Y., Hsi, J.H., Takebe, Y., Shao, Y., A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One, 7, 2012, e47289, 10.1371/journal.pone.0047289.
87. Hemelaar, J., Gouws, E., Ghys, P.D., Osmanov, S., Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25 (2011), 679–689, 10.1097/QAD.0b013e328342ff93.
88. Hersh, B.S., Popovici, F., Apetrei, R.C., Zolotusca, L., Beldescu, N., Calomfirescu, A., Jezek, Z., Oxtoby, M.J., Gromyko, A., Heymann, D.L., Acquired immunodeficiency syndrome in Romania. Lancet 338 (1991), 645–649.
89. Hersh, B.S., Popovici, F., Jezek, Z., Satten, G.A., Apetrei, R.C., Beldescu, N., George, J.R., Shapiro, C.N., Gayle, H.D., Heymann, D.L., Risk factors for HIV infection among abandoned Romanian children. AIDS 7 (1993), 1617–1624.
90. Holguín, A., de Mulder, M., Yebra, G., López, M., Soriano, V., Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr. HIV Res. 6 (2008), 327–334.
91. Huang, S.-W., Wang, S.-F., Lin, Y.-T., Yen, C.-H., Lee, C.-H., Wong, W.-W., Tsai, H.-C., Yang, C.-J., Hu, B.-S., Lin, Y.-H., Wang, C.-T., Wang, J.-J., Hu, Z., Kuritzkes, D.R., Chen, Y.-H., Chen, Y.-M.A., Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression. PLoS One, 9, 2014, e114441, 10.1371/journal.pone.0114441.
92. Ibe, S., Yokomaku, Y., Shiino, T., Tanaka, R., Hattori, J., Fujisaki, S., Iwatani, Y., Mamiya, N., Utsumi, M., Kato, S., Hamaguchi, M., Sugiura, W., HIV-2 CRF01_AB: first circulating recombinant form of HIV-2. J. Acquir. Immune Defic. Syndr. 54 (2010), 241–247, 10.1097/QAI.0b013e3181dc98c1.
93. Jahanbakhsh, F., Hattori, J., Matsuda, M., Ibe, S., Monavari, S.-H.R., Memarnejadian, A., Aghasadeghi, M.R., Mostafavi, E., Mohraz, M., Jabbari, H., Kamali, K., Keyvani, H., Azadmanesh, K., Sugiura, W., Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. PLoS One, 8, 2013, e61864, 10.1371/journal.pone.0061864.
94. Jahanbakhsh, F., Ibe, S., Hattori, J., Monavari, S.H.R., Matsuda, M., Maejima, M., Iwatani, Y., Memarnejadian, A., Keyvani, H., Azadmanesh, K., Sugiura, W., Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use. AIDS Res. Hum. Retrovir. 29 (2013), 198–203, 10.1089/AID.2012.0186.
95. Junqueira, D.M., Almeida, S.E.d.M., HIV-1 subtype B: traces of a pandemic. Virology 495 (2016), 173–184, 10.1016/j.virol.2016.05.003.
96. Kamarulzaman, A., Altice, F.L., Challenges in managing HIV in people who use drugs. Curr. Opin. Infect. Dis. 28 (2015), 10–16, 10.1097/QCO.0000000000000125.
97. Kato, K., Shiino, T., Kusagawa, S., Sato, H., Nohtomi, K., Shibamura, K., Nguyen, T.H., Pham, K.C., Truong, X.L., Mai, H.A., Hoang, T.L., Bunyaraksyotin, G., Fukushima, Y., Honda, M., Wasi, C., Yamazaki, S., Nagai, Y., Takebe, Y., Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China. AIDS Res. Hum. Retrovir. 15 (1999), 1157–1168, 10.1089/088922299310250.
98. Kato, K., Kusagawa, S., Motomura, K., Yang, R., Shiino, T., Nohtomi, K., Sato, H., Shibamura, K., Nguyen, T.H., Pham, K.C., Pham, H.T., Duong, C.T., Bui, D.T., Hoang, T.L., Nagai, Y., Takebe, Y., Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam–China border. AIDS Res. Hum. Retrovir. 17 (2001), 113–123, 10.1089/08892220150217201.
99. Kazennova, E., Laga, V., Lapovok, I., Glushchenko, N., Neshumaev, D., Vasilyev, A., Bobkova, M., HIV-1 genetic variants in the Russian Far East. AIDS Res. Hum. Retrovir. 30 (2014), 742–752, 10.1089/AID.2013.0194.
100. Keele, B.F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M.L., Bibollet-Ruche, F., Chen, Y., Wain, L.V., Liegeois, F., Loul, S., Ngole, E.M., Bienvenue, Y., Delaporte, E., Brookfield, J.F.Y., Sharp, P.M., Shaw, G.M., Peeters, M., Hahn, B.H., Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313 (2006), 523–526, 10.1126/science.1126531.
101. Khajehkazemi, R., Osooli, M., Sajadi, L., Karamouzian, M., Sedaghat, A., Fahimfar, N., Safaie, A., Mostafavi, E., Haghdoost, A.-A., HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex. Transm. Infect. 89:Suppl. 3 (2013), iii29–iii32, 10.1136/sextrans-2013-051204.
102. Khan, S., Rai, M.A., Khanani, M.R., Khan, M.N., Ali, S.H., HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect. Dis., 6, 2006, 164, 10.1186/1471-2334-6-164.
103. Kijak, G.H., Tovanabutra, S., Rerks-Ngarm, S., Nitayaphan, S., Eamsila, C., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Namwat, C., Premsri, N., Benenson, M., Morgan, P., Bose, M., Sanders-Buell, E., Paris, R., Robb, M.L., Birx, D.L., De Souza, M.S., McCutchan, F.E., Michael, N.L., Kim, J.H., Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial. J. Virol. 87 (2013), 7265–7281, 10.1128/JVI.03070-12.
104. Kivelä, P.S., Krol, A., Salminen, M.O., Geskus, R.B., Suni, J.I., Anttila, V.-J., Liitsola, K., Zetterberg, V., Miedema, F., Berkhout, B., Coutinho, R.A., Ristola, M.A., High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland. Scand. J. Infect. Dis. 37 (2005), 276–283.
105. Kivelä, P., Krol, A., Simola, S., Vaattovaara, M., Tuomola, P., Brummer-Korvenkontio, H., Ristola, M., HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets. Eur. J. Pub. Health 17 (2007), 381–386, 10.1093/eurpub/ckl252.
106. Kiwanuka, N., Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L.A., Eller, M., Makumbi, F., Birx, D., Wabwire-Mangen, F., Serwadda, D., Sewankambo, N.K., Quinn, T.C., Wawer, M., Gray, R., Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J. Infect. Dis. 197 (2008), 707–713, 10.1086/527416.
107. Kiwanuka, N., Laeyendecker, O., Quinn, T.C., Wawer, M.J., Shepherd, J., Robb, M., Kigozi, G., Kagaayi, J., Serwadda, D., Makumbi, F.E., Reynolds, S.J., Gray, R.H., HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 23 (2009), 2479–2484, 10.1097/QAD.0b013e328330cc08.
108. Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B.H., Wolinsky, S., Bhattacharya, T., Timing the ancestor of the HIV-1 pandemic strains. Science 288 (2000), 1789–1796.
109. Kuiken, C., Thakallapalli, R., Esklid, A., de Ronde, A., Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am. J. Epidemiol. 152 (2000), 814–822.
110. Kurbanov, F., Kondo, M., Tanaka, Y., Zalalieva, M., Giasova, G., Shima, T., Jounai, N., Yuldasheva, N., Ruzibakiev, R., Mizokami, M., Imai, M., Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. AIDS Res. Hum. Retrovir. 19 (2003), 731–738, 10.1089/088922203769232520.
111. Kusagawa, S., Sato, H., Watanabe, S., Nohtomi, K., Kato, K., Shino, T., Thwe, M., OO, K.Y., Lwin, S., Mra, R., Kywe, B., Yamazaki, S., Takebe, Y., Genetic and serologic characterization of HIV type 1 prevailing in Myanmar (Burma). AIDS Res. Hum. Retrovir. 14 (1998), 1379–1385.
112. Kusagawa, S., Sato, H., Kato, K., Nohtomi, K., Shiino, T., Samrith, C., Leng, H.B., Phalla, T., Heng, M.B., Takebe, Y., HIV type 1 env subtype E in Cambodia. AIDS Res. Hum. Retrovir. 15 (1999), 91–94, 10.1089/088922299311772.
113. Laeyendecker, O., Zhang, G.W., Quinn, T.C., Garten, R., Ray, S.C., Lai, S., Liu, W., Chen, J., Yu, X.-F., Molecular epidemiology of HIV-1 subtypes in southern China. J. Acquir. Immune Defic. Syndr. 38 (2005), 356–362.
114. Laga, V., Lapovok, I., Kazennova, E., Ismailova, A., Beisheeva, N., Asybalieva, N., Glushchenko, N., Bobkova, M., The genetic variability of HIV-1 in Kyrgyzstan: the spread of CRF02_AG and subtype A1 recombinants. J. HIV AIDS, 1, 2015, 10.16966/2380-5536.106.
115. Laga, V., Vasilyev, A., Lapovok, I., Grigoryan, S., Papoyan, A., Glushchenko, N., Kazennova, E., Bobkova, M., HIV type 1 subtype A1 dominates in Armenia. Curr. HIV Res. 13 (2015), 219–225.
116. Lai, A., Bozzi, G., Franzetti, M., Binda, F., Simonetti, F.R., De Luca, A., Micheli, V., Meraviglia, P., Bagnarelli, P., Di Biagio, A., Monno, L., Saladini, F., Zazzi, M., Zehender, G., Ciccozzi, M., Balotta, C., HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users. PLoS One, 11, 2016, e0146097, 10.1371/journal.pone.0146097.
117. Lan, N.T.H., Recordon-Pinson, P., Hung, P.V., Uyen, N.T.V., Lien, T.T.X., Tien, H.T., Garrigue, I., Schrive, M.-H., Pellegrin, I., Lafon, M.-E., Aboulker, J.-P., Barré-Sinousi, F., Fleury, H.J., HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. AIDS Res. Hum. Retroviruses 19 (2003), 925–928, 10.1089/088922203322493111.
118. Lapovok, I., Kazennova, E., Laga, V., Vasilyev, A., Utegenova, A., Abishev, A., Dzissyuk, N., Tukeev, M., Bobkova, M., Short communication: molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces. AIDS Res. Hum. Retrovir. 30 (2014), 769–774, 10.1089/AID.2013.0291.
119. Larsen, M.V., Omland, L.H., Gerstoft, J., Røge, B.T., Larsen, C.S., Pedersen, G., Obel, N., Kronborg, G., Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study. Scand. J. Infect. Dis. 42 (2010), 917–923, 10.3109/00365548.2010.511258.
120. Lau, K.A., Wong, J.J.L., Current trends of HIV recombination worldwide. Infect. Dis. Rep., 5, 2013, e4, 10.4081/idr.2013.s1.e4.
121. Lau, K.A., Wang, B., Saksena, N.K., Emerging trends of HIV epidemiology in Asia. AIDS Rev. 9 (2007), 218–229.
122. Lazouskaya, N.V., Eremin, V.F., Adema, K.W., Gasich, E.L., Baan, E., Lukashov, V.V., The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. AIDS Res. Hum. Retrovir. 21 (2005), 830–833, 10.1089/aid.2005.21.830.
123. Li, Y., Tee, K.K., Liao, H., Hase, S., Uenishi, R., Li, X.-J., Tsuchiura, T., Yang, R., Govindasamy, S., Yong, Y.K., Tan, H.Y., Pybus, O.G., Kamarulzaman, A., Takebe, Y., Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B. J. Acquir. Immune Defic. Syndr. 54 (2010), 129–136, 10.1097/QAI.0b013e3181d82ce5.
124. Li, Y., Uenishi, R., Hase, S., Liao, H., Li, X.-J., Tsuchiura, T., Tee, K.K., Pybus, O.G., Takebe, Y., Explosive HIV-1 subtype B’ epidemics in Asia driven by geographic and risk group founder events. Virology 402 (2010), 223–227, 10.1016/j.virol.2010.03.048.
125. Li, L., Wei, D., Hsu, W.-L., Li, T., Gui, T., Wood, C., Liu, Y., Li, H., Bao, Z., Liu, S., Wang, X., Li, J., CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan Prefecture of Sichuan, China. AIDS Res. Hum. Retroviruses 31 (2015), 479–487, 10.1089/AID.2014.0120.
126. Liao, H., Tee, K.K., Hase, S., Uenishi, R., Li, X.-J., Kusagawa, S., Thang, P.H., Hien, N.T., Pybus, O.G., Takebe, Y., Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. Virology 391 (2009), 51–56, 10.1016/j.virol.2009.05.023.
127. Liitsola, K., Tashkinova, I., Laukkanen, T., Korovina, G., Smolskaja, T., Momot, O., Mashkilleyson, N., Chaplinskas, S., Brummer-Korvenkontio, H., Vanhatalo, J., Leinikki, P., Salminen, M.O., HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 12 (1998), 1907–1919.
128. Liitsola, K., Holm, K., Bobkov, A., Pokrovsky, V., Smolskaya, T., Leinikki, P., Osmanov, S., Salminen, M., An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. AIDS Res. Hum. Retroviruses 16 (2000), 1047–1053, 10.1089/08892220050075309.
129. Liitsola, K., Ristola, M., Holmström, P., Salminen, M., Brummer-Korvenkontio, H., Simola, S., Suni, J., Leinikki, P., An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS 14 (2000), 2613–2615.
130. Lin, H.-H., Shih, Y.-L., Liu, Y.-C., Lee, S.S.-J., Huang, C.-K., Chen, Y.-L., Chin, C., Lai, C.-H., Tsai, H.-C., Guo, Y.-C., Zhang, L., An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan. J. Acquir. Immune Defic. Syndr. 42 (2006), 248–255, 10.1097/01.qai.0000214818.80539.da.
131. Linka, M., Brůcková, M., Malý, M., Vandasová, J., Stanková, M., Reinis, M., A study of HIV-1 genetic diversity in the Czech Republic: 1986–2007. Cent. Eur. J. Public Health 16 (2008), 175–177.
132. Liu, J., Jia, Y., Xu, Q., Zheng, Y.-T., Zhang, C., Phylodynamics of HIV-1 unique recombinant forms in China–Myanmar border: implication for HIV-1 transmission to Myanmar from Dehong, China. Infect. Genet. Evol. 12 (2012), 1944–1948, 10.1016/j.meegid.2012.08.001.
133. Lospitao, E., Alvarez, A., Soriano, V., Holguín, A., HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med. 6 (2005), 313–320, 10.1111/j.1468-1293.2005.00313.x.
134. Lukashov, V.V., Cornelissen, M.T., Goudsmit, J., Papuashvilli, M.N., Rytik, P.G., Khaitov, R.M., Karamov, E.V., de Wolf, F., Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania. AIDS 9 (1995), 435–439.
135. Lukashov, V.V., Kuiken, C.L., Vlahov, D., Coutinho, R.A., Goudsmit, J., Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res. Hum. Retroviruses 12 (1996), 1179–1183.
136. Lukashov, V.V., Karamov, E.V., Eremin, V.F., Titov, L.P., Goudsmit, J., Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. AIDS Res. Hum. Retroviruses 14 (1998), 1299–1303.
137. Lukashov, V.V., Huismans, R., Rakhmanova, A.G., Lisitsina, Z.N., Akhtyrskaya, N.A., Vlasov, N.N., Melnick, O.B., Goudsmit, J., Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res. Hum. Retroviruses 15 (1999), 1577–1583, 10.1089/088922299309874.
138. MacArthur, G.J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V., Taylor, A., Roy, K., Aspinall, E., Goldberg, D., Rhodes, T., Hedrich, D., Salminen, M., Hickman, M., Hutchinson, S.J., Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int. J. Drug Policy 25 (2014), 34–52, 10.1016/j.drugpo.2013.07.001.
139. Mandal, D., Jana, S., Bhattacharya, S.K., Chakrabarti, S., HIV type 1 subtypes circulating in eastern and northeastern regions of India. AIDS Res. Hum. Retrovir. 18 (2002), 1219–1227, 10.1089/08892220260387968.
140. Mathers, B.M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S.A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., Mattick, R.P., Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372 (2008), 1733–1745, 10.1016/S0140-6736(08)61311-2.
141. Mathers, B.M., Degenhardt, L., Bucello, C., Lemon, J., Wiessing, L., Hickman, M., Mortality among people who inject drugs: a systematic review and meta-analysis. Bull. World Health Organ. 91 (2013), 102–123, 10.2471/BLT.12.108282.
142. McCormack, S., Dunn, D.T., Desai, M., Dolling, D.I., Gafos, M., Gilson, R., Sullivan, A.K., Clarke, A., Reeves, I., Schembri, G., Mackie, N., Bowman, C., Lacey, C.J., Apea, V., Brady, M., Fox, J., Taylor, S., Antonucci, S., Khoo, S.H., Rooney, J., Nardone, A., Fisher, M., McOwan, A., Phillips, A.N., Johnson, A.M., Gazzard, B., Gill, O.N., Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet, 2015, 10.1016/S0140-6736(15)00056-2.
143. Memarnejadian, A., Menbari, S., Mansouri, S.A., Sadeghi, L., Vahabpour, R., Aghasadeghi, M.R., Mostafavi, E., Abdi, M., Transmitted drug resistance mutations in antiretroviral-naïve injection drug users with chronic HIV-1 infection in Iran. PLoS One, 10, 2015, e0126955, 10.1371/journal.pone.0126955.
144. Menu, E., Truong, T.X., Lafon, M.E., Nguyen, T.H., Müller-Trutwin, M.C., Nguyen, T.T., Deslandres, A., Chaouat, G., Duong, Q.T., Ha, B.K., Fleury, H.J., Barré-Sinoussi, F., HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res. Hum. Retrovir. 12 (1996), 629–633.
145. Menu, E., Reynes, J.M., Müller-Trutwin, M.C., Guillemot, L., Versmisse, P., Chiron, M., An, S., Trouplin, V., Charneau, P., Fleury, H., Barré-Sinoussi, F., Sainte Marie, F.F., Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20 (1999), 481–487.
146. Mezei, M., Ay, E., Koroknai, A., Tóth, R., Balázs, A., Bakos, A., Gyori, Z., Bánáti, F., Marschalkó, M., Kárpáti, S., Minárovits, J., Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary. AIDS Res. Hum. Retrovir. 27 (2011), 1243–1247, 10.1089/aid.2011.0077.
147. Mills, E.J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C.L., Nachega, J.B., Dybul, M., Hogg, R.S., Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann. Intern. Med. 155 (2011), 209–216, 10.7326/0003-4819-155-4-201108160-00358.
148. Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., Raffi, F., Pintado, C., Chidiac, C., Chas, J., Charbonneau, P., Delaugerre, C., Suzan-Monti, M., Loze, B., Fonsart, J., Peytavin, G., Cheret, A., Timsit, J., Girard, G., Lorente, N., Préau, M., Rooney, J.F., Wainberg, M.A., Thompson, D., Rozenbaum, W., Doré, V., Marchand, L., Simon, M.-C., Etien, N., Aboulker, J.-P., Meyer, L., Delfraissy, J.-F., On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N. Engl. J. Med. 373 (2015), 2237–2246, 10.1056/NEJMoa1506273.
149. Montavon, C., Toure-Kane, C., Nkengasong, J.N., Vergne, L., Hertogs, K., Mboup, S., Delaporte, E., Peeters, M., CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J. Acquir. Immune Defic. Syndr. 29 (2002), 522–530.
150. Motomura, K., Kusagawa, S., Kato, K., Nohtomi, K., Lwin, H.H., Tun, K.M., Thwe, M., Oo, K.Y., Lwin, S., Kyaw, O., Zaw, M., Nagai, Y., Takebe, Y., Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar. AIDS Res. Hum. Retrovir. 16 (2000), 1831–1843, 10.1089/08892220050195793.
151. Mousavi, S.M., Hamkar, R., Gouya, M.M., Safaie, A., Zahraei, S.M., Yazdani, Z., Asbaghi Namini, S., Bertagnolio, S., Sutherland, D., Sandstrom, P., Brooks, J., Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch. Virol. 155 (2010), 329–334, 10.1007/s00705-009-0583-6.
152. Mullick, R., Sengupta, S., Sarkar, K., Chakrabarti, S., Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants. Virus Res. 147 (2010), 195–201, 10.1016/j.virusres.2009.10.024.
153. Murray, M., Hogg, R.S., Lima, V.D., May, M.T., Moore, D.M., Abgrall, S., Bruyand, M., D'Arminio Monforte, A., Tural, C., Gill, M.J., Harris, R.J., Reiss, P., Justice, A., Kirk, O., Saag, M., Smith, C.J., Weber, R., Rockstroh, J., Khaykin, P., Sterne, J.A.C., The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Med. 13 (2012), 89–97, 10.1111/j.1468-1293.2011.00940.x.
154. Nabatov, A.A., Kravchenko, O.N., Lyulchuk, M.G., Shcherbinskaya, A.M., Lukashov, V.V., Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res. Hum. Retrovir. 18 (2002), 891–895, 10.1089/08892220260190380.
155. Naderi, H.R., Tagliamonte, M., Tornesello, M.L., Ciccozzi, M., Rezza, G., Farid, R., Buonaguro, F.M., Buonaguro, L., Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. Infect. Agent. Cancer, 1, 2006, 4, 10.1186/1750-9378-1-4.
156. Nahmias, A.J., Weiss, J., Yao, X., Lee, F., Kodsi, R., Schanfield, M., Matthews, T., Bolognesi, D., Durack, D., Motulsky, A., Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. Lancet 1 (1986), 1279–1280.
157. Neogi, U., Sood, V., Ronsard, L., Singh, J., Lata, S., Ramachandran, V.G., Das, S., Wanchu, A., Banerjea, A.C., Genetic architecture of HIV-1 genes circulating in north India & their functional implications. Indian J. Med. Res. 134 (2011), 769–778, 10.4103/0971-5916.92624.
158. Neogi, U., Bontell, I., Shet, A., De Costa, A., Gupta, S., Diwan, V., Laishram, R.S., Wanchu, A., Ranga, U., Banerjea, A.C., Sönnerborg, A., Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C. PLoS One, 7, 2012, e39819, 10.1371/journal.pone.0039819.
159. Ng, K.T., Ong, L.Y., Takebe, Y., Kamarulzaman, A., Tee, K.K., Genome sequence of a novel HIV-1 circulating recombinant form 54_01B from Malaysia. J. Virol. 86 (2012), 11405–11406, 10.1128/JVI.01949-12.
160. Niculescu, I., Paraschiv, S., Paraskevis, D., Abagiu, A., Batan, I., Banica, L., Otelea, D., Recent HIV-1 outbreak among intravenous drug users in Romania: evidence for cocirculation of CRF14_BG and subtype F1 strains. AIDS Res. Hum. Retrovir. 31 (2015), 488–495, 10.1089/aid.2014.0189.
161. Nikolopoulos, G., Paraskevis, D., Hatzakis, A., HIV epidemiology in Greece. Future Microbiol 3 (2008), 507–516, 10.2217/17460913.3.5.507.
162. Nikolopoulos, G.K., Fotiou, A., Kanavou, E., Richardson, C., Detsis, M., Pharris, A., Suk, J.E., Semenza, J.C., Costa-Storti, C., Paraskevis, D., Sypsa, V., Malliori, M.-M., Friedman, S.R., Hatzakis, A., National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in europe: a panel data analysis. PLoS One, 10, 2015, e0122367, 10.1371/journal.pone.0122367.
163. Nikolopoulos, G.K., Sypsa, V., Bonovas, S., Paraskevis, D., Malliori-Minerva, M., Hatzakis, A., Friedman, S.R., Big events in Greece and HIV infection among people who inject drugs. Subst. Use Misuse 50 (2015), 825–838, 10.3109/10826084.2015.978659.
164. Novitsky, V.A., Montano, M.A., Essex, M., Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res. Hum. Retrovir. 14 (1998), 1079–1085.
165. Nsanzimana, S., Remera, E., Kanters, S., Chan, K., Forrest, J.I., Ford, N., Condo, J., Binagwaho, A., Mills, E.J., Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob. Health 3 (2015), e169–e177, 10.1016/S2214-109X(14)70364-X.
166. Oelrichs, R.B., Shrestha, I.L., Anderson, D.A., Deacon, N.J., The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J. Virol. 74 (2000), 1149–1157.
167. Ou, C.Y., Takebe, Y., Weniger, B.G., Luo, C.C., Kalish, M.L., Auwanit, W., Yamazaki, S., Gayle, H.D., Young, N.L., Schochetman, G., Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341 (1993), 1171–1174.
168. Palma, A.C., Araújo, F., Duque, V., Borges, F., Paixão, M.T., Camacho, R., Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect. Genet. Evol. 7 (2007), 391–398, 10.1016/j.meegid.2007.01.009.
169. Pandrea, I., Descamps, D., Collin, G., Robertson, D.L., Damond, F., Dimitrienco, V., Gheorghita, S., Pecec, M., Simon, F., Brun-Vézinet, F., Apetrei, C., HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova. AIDS Res. Hum. Retrovir. 17 (2001), 1297–1304, 10.1089/088922201750461375.
170. Pang, W., Zhang, C., Duo, L., Zhou, Y.-H., Yao, Z.-H., Liu, F.-L., Li, H., Tu, Y.-Q., Zheng, Y.-T., Extensive and complex HIV-1 recombination between B’, C and CRF01_AE among IDUs in south-east Asia. AIDS 26 (2012), 1121–1129, 10.1097/QAD.0b013e3283522c97.
171. Paraskevis, D., Magiorkinis, E., Magiorkinis, G., Sypsa, V., Paparizos, V., Lazanas, M., Gargalianos, P., Antoniadou, A., Panos, G., Chrysos, G., Sambatakou, H., Karafoulidou, A., Skoutelis, A., Kordossis, T., Koratzanis, G., Theodoridou, M., Daikos, G.L., Nikolopoulos, G., Pybus, O.G., Hatzakis, A., Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J. Infect. Dis. 196 (2007), 1167–1176, 10.1086/521677.
172. Paraskevis, D., Nikolopoulos, G., Tsiara, C., Paraskeva, D., Antoniadou, A., Lazanas, M., Gargalianos, P., Psychogiou, M., Malliori, M., Kremastinou, J., Hatzakis, A., HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill., 16, 2011.
173. Paraskevis, D., Nikolopoulos, G., Fotiou, A., Tsiara, C., Paraskeva, D., Sypsa, V., Lazanas, M., Gargalianos, P., Psichogiou, M., Skoutelis, A., Wiessing, L., Friedman, S.R., Jarlais, D.C.D.E.S., Terzidou, M., Kremastinou, J., Malliori, M., Hatzakis, A., Economic recession and emergence of an HIV-1 outbreak among drug injectors in athens metropolitan area: a longitudinal study. PLoS One, 8, 2013, e78941, 10.1371/journal.pone.0078941.
174. Paraskevis, D., Paraschiv, S., Sypsa, V., Nikolopoulos, G., Tsiara, C., Magiorkinis, G., Psichogiou, M., Flampouris, A., Mardarescu, M., Niculescu, I., Batan, I., Malliori, M., Otelea, D., Hatzakis, A., Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest. Infect. Genet. Evol. 35 (2015), 109–121, 10.1016/j.meegid.2015.08.004.
175. Parczewski, M., Leszczyszyn-Pynka, M., Witak-Jędra, M., Rymer, W., Zalewska, M., Gąsiorowski, J., Bociąga-Jasik, M., Kalinowska-Nowak, A., Garlicki, A., Grzeszczuk, A., Jankowska, M., Lemańska, M., Barałkiewicz, G., Mozer-Lisewska, I., Łojewski, W., Grąbczewska, E., Olczak, A., Jabłonowska, E., Urbańska, A., Distribution and time trends of HIV-1 variants in Poland: characteristics of non-B clades and recombinant viruses. Infect. Genet. Evol. 39 (2016), 232–240, 10.1016/j.meegid.2016.02.001.
176. Patel, P., Borkowf, C.B., Brooks, J.T., Lasry, A., Lansky, A., Mermin, J., Estimating per-act HIV transmission risk: a systematic review. AIDS 28 (2014), 1509–1519, 10.1097/QAD.0000000000000298.
177. Peeters, M., Gueye, A., Mboup, S., Bibollet-Ruche, F., Ekaza, E., Mulanga, C., Ouedrago, R., Gandji, R., Mpele, P., Dibanga, G., Koumare, B., Saidou, M., Esu-Williams, E., Lombart, J.P., Badombena, W., Luo, N., Vanden Haesevelde, M., Delaporte, E., Geographical distribution of HIV-1 group O viruses in Africa. AIDS 11 (1997), 493–498.
178. Peeters, M., Jung, M., Ayouba, A., The origin and molecular epidemiology of HIV. Expert Rev. Anti-Infect. Ther. 11 (2013), 885–896, 10.1586/14787210.2013.825443.
179. Pérez-Alvarez, L., Carmona, R., Muñoz, M., Delgado, E., Thomson, M.M., Contreras, G., Pedreira, J.D., Rodríguez Real, R., Vázquez de Parga, E., Medrano, L., Taboada, J.A., Nájera, R., High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance. Antivir. Ther. 8 (2003), 355–360.
180. Piyasirisilp, S., McCutchan, F.E., Carr, J.K., Sanders-Buell, E., Liu, W., Chen, J., Wagner, R., Wolf, H., Shao, Y., Lai, S., Beyrer, C., Yu, X.F., A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J. Virol. 74 (2000), 11286–11295.
181. Plantier, J.-C., Leoz, M., Dickerson, J.E., De Oliveira, F., Cordonnier, F., Lemée, V., Damond, F., Robertson, D.L., Simon, F., A new human immunodeficiency virus derived from gorillas. Nat. Med. 15 (2009), 871–872, 10.1038/nm.2016.
182. Ramos, A., Hu, D.J., Nguyen, L., Phan, K.-O., Vanichseni, S., Promadej, N., Choopanya, K., Callahan, M., Young, N.L., McNicholl, J., Mastro, T.D., Folks, T.M., Subbarao, S., Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 76 (2002), 7444–7452.
183. Reinis, M., Brucková, M., Graham, R.R., Vandasová, J., Stanková, M., Carr, J.K., Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic. AIDS Res. Hum. Retrovir. 17 (2001), 1305–1310, 10.1089/088922201750461384.
184. Renjifo, B., Gilbert, P., Chaplin, B., Msamanga, G., Mwakagile, D., Fawzi, W., Essex, M., Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 18 (2004), 1629–1636.
185. Rhodes, T., Simic, M., Transition and the HIV risk environment. BMJ 331 (2005), 220–223, 10.1136/bmj.331.7510.220.
186. Roques, P., Robertson, D.L., Souquière, S., Damond, F., Ayouba, A., Farfara, I., Depienne, C., Nerrienet, E., Dormont, D., Brun-Vézinet, F., Simon, F., Mauclère, P., Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology 302 (2002), 259–273.
187. Roques, P., Robertson, D.L., Souquière, S., Apetrei, C., Nerrienet, E., Barré-Sinoussi, F., Müller-Trutwin, M., Simon, F., Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. AIDS 18 (2004), 1371–1381.
188. Rumyantseva, O.A., Olkhovskiy, I.A., Malysheva, M.A., Ruzaeva, L.A., Vasiliev, A.V., Kazennova, E.V., Bobkova, M.R., Lukashov, V.V., Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia. AIDS Res. Hum. Retroviruses 25 (2009), 931–936, 10.1089/aid.2009.0075.
189. Saad, M.D., Aliev, Q., Botros, B.A.M., Carr, J.K., Gomatos, P.J., Nadai, Y., Michael, A.A., Nasibov, Z., Sanchez, J.L., Brix, D.I., Earhart, K.C., Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. AIDS Res. Hum. Retrovir. 22 (2006), 796–800, 10.1089/aid.2006.22.796.
190. Saad, M.D., Shcherbinskaya, A.M., Nadai, Y., Kruglov, Y.V., Antonenko, S.V., Lyullchuk, M.G., Kravchenko, O.N., Earhart, K.C., Sanchez, J.L., Birx, D.L., Carr, J.K., Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic. AIDS Res. Hum. Retrovir. 22 (2006), 709–714, 10.1089/aid.2006.22.709.
191. Sahbandar, I.N., Takahashi, K., Djoerban, Z., Firmansyah, I., Naganawa, S., Motomura, K., Sato, H., Kitamura, K., Pohan, H.T., Sato, S., Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. AIDS Res. Hum. Retroviruses 25 (2009), 637–646, 10.1089/aid.2008.0266.
192. Samji, H., Cescon, A., Hogg, R.S., Modur, S.P., Althoff, K.N., Buchacz, K., Burchell, A.N., Cohen, M., Gebo, K.A., Gill, M.J., Justice, A., Kirk, G., Klein, M.B., Korthuis, P.T., Martin, J., Napravnik, S., Rourke, S.B., Sterling, T.R., Silverberg, M.J., Deeks, S., Jacobson, L.P., Bosch, R.J., Kitahata, M.M., Goedert, J.J., Moore, R., Gange, S.J., Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8, 2013, e81355, 10.1371/journal.pone.0081355.
193. Sanders-Buell, E., Saad, M.D., Abed, A.M., Bose, M., Todd, C.S., Strathdee, S.A., Botros, B.A., Safi, N., Earhart, K.C., Scott, P.T., Michael, N., McCutchan, F.E., A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. AIDS Res. Hum. Retrovir. 23 (2007), 834–839, 10.1089/aid.2006.0299.
194. Sanders-Buell, E., Bose, M., Nasir, A., Todd, C.S., Stanekzai, M.R., Tovanabutra, S., Scott, P.T., Strathdee, S.A., Tjaden, J., Michael, N.L., McCutchan, F.E., Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan. AIDS Res. Hum. Retrovir. 26 (2010), 605–608, 10.1089/aid.2009.0226.
195. Saraswathy, T.S., Ng, K.P., Sinniah, M., Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users. Southeast Asian J. Trop. Med. Public Health 31 (2000), 283–286.
196. Sarkar, R., Sengupta, S., Mullick, R., Singh, N.B., Sarkar, K., Chakrabarti, S., Implementation of a multiregion hybridization assay to characterize HIV-1 strains detected among injecting drug users in Manipur, India. Intervirology 52 (2009), 175–178, 10.1159/000224645.
197. Sarker, M.S., Rahman, M., Yirrell, D., Campbell, E., Rahman, A.S.M.M., Islam, L.N., Azim, T., Molecular evidence for polyphyletic origin of human immunodeficiency virus type 1 subtype C in Bangladesh. Virus Res. 135 (2008), 89–94, 10.1016/j.virusres.2008.02.010.
198. Sarrami-Forooshani, R., Das, S.R., Sabahi, F., Adeli, A., Esmaeili, R., Wahren, B., Mohraz, M., Haji-Abdolbaghi, M., Rasoolinejad, M., Jameel, S., Mahboudi, F., Molecular analysis and phylogenetic characterization of HIV in Iran. J. Med. Virol. 78 (2006), 853–863, 10.1002/jmv.20634.
199. Shah, S., Xing, H., Altaf, A., Chen, B., Liao, L., Jia, Y., Vermund, S.H., Shao, Y., Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan. AIDS Res. Hum. Retrovir. 27 (2011), 1277–1282, 10.1089/AID.2010.0324.
200. Shahid, A., Dixit, S.M., Gurbacharya, V.L., Karmacharya, D., Ali, S., HIV-1 circulating recombinant form in Nepal. J. Virol., 85, 2011, 8458, 10.1128/JVI.05108-11.
201. Sharp, P.M., Hahn, B.H., Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med., 1, 2011, a006841, 10.1101/cshperspect.a006841.
202. Shen, C., Craigo, J., Ding, M., Chen, Y., Gupta, P., Origin and dynamics of HIV-1 subtype C infection in India. PLoS One, 6, 2011, e25956, 10.1371/journal.pone.0025956.
203. Shiino, T., Hattori, J., Yokomaku, Y., Iwatani, Y., Sugiura, W., Phylodynamic analysis reveals CRF01_AE dissemination between Japan and neighboring Asian countries and the role of intravenous drug use in transmission. PLoS One, 9, 2014, e102633, 10.1371/journal.pone.0102633.
204. Simon, F., Mauclère, P., Roques, P., Loussert-Ajaka, I., Müller-Trutwin, M.C., Saragosti, S., Georges-Courbot, M.C., Barré-Sinoussi, F., Brun-Vézinet, F., Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4 (1998), 1032–1037, 10.1038/2017.
205. Skar, H., Axelsson, M., Berggren, I., Thalme, A., Gyllensten, K., Liitsola, K., Brummer-Korvenkontio, H., Kivelä, P., Spångberg, E., Leitner, T., Albert, J., Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland. J. Virol. 85 (2011), 510–518, 10.1128/JVI.01413-10.
206. Smoleń-Dzirba, J., Rosińska, M., Kruszyński, P., Bratosiewicz-Wąsik, J., Janiec, J., Beniowski, M., Bociąga-Jasik, M., Jabłonowska, E., Szetela, B., Porter, K., Wąsik, T.J., Molecular epidemiology of recent HIV-1 infections in southern Poland. J. Med. Virol. 84 (2012), 1857–1868, 10.1002/jmv.23395.
207. Smolskaya, T., Liitsola, K., Zetterberg, V., Golovanova, E., Kevlova, N., Konovalova, N., Sevastianova, K., Brummer-Korvenkontio, H., Salminen, M., HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A. AIDS Res. Hum. Retrovir. 22 (2006), 1074–1080, 10.1089/aid.2006.22.1074.
208. Soriano, V., Gomes, P., Heneine, W., Holguín, A., Doruana, M., Antunes, R., Mansinho, K., Switzer, W.M., Araujo, C., Shanmugam, V., Lourenço, H., González-Lahoz, J., Antunes, F., Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61 (2000), 111–116.
209. Stanojevic, M., Alexiev, I., Beshkov, D., Gökengin, D., Mezei, M., Minarovits, J., Otelea, D., Paraschiv, S., Poljak, M., Zidovec-Lepej, S., Paraskevis, D., HIV-1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity. AIDS Rev. 14 (2012), 28–36.
210. Stephenson, K.E., Barouch, D.H., A global approach to HIV-1 vaccine development. Immunol. Rev. 254 (2013), 295–304, 10.1111/imr.12073.
211. Strathdee, S.A., Stockman, J.K., Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr. HIV/AIDS Rep. 7 (2010), 99–106, 10.1007/s11904-010-0043-7.
212. Strathdee, S.A., Stachowiak, J.A., Todd, C.S., Al-Delaimy, W.K., Wiebel, W., Hankins, C., Patterson, T.L., Complex emergencies, HIV, and substance use: no “big easy” solution. Subst. Use Misuse 41 (2006), 1637–1651, 10.1080/10826080600848116.
213. Subbarao, S., Limpakarnjanarat, K., Mastro, T.D., Bhumisawasdi, J., Warachit, P., Jayavasu, C., Young, N.L., Luo, C.C., Shaffer, N., Kalish, M.L., Schochetman, G., HIV type 1 in Thailand, 1994–1995: persistence of two subtypes with low genetic diversity. AIDS Res. Hum. Retrovir. 14 (1998), 319–327.
214. Tagliamonte, M., Naderi, H.R., Tornesello, M.L., Farid, R., Buonaguro, F.M., Buonaguro, L., HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran. AIDS Res. Hum. Retrovir. 23 (2007), 1569–1574, 10.1089/aid.2007.0169.
215. Takebe, Y., Motomura, K., Tatsumi, M., Lwin, H.H., Zaw, M., Kusagawa, S., High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination. AIDS 17 (2003), 2077–2087, 10.1097/01.aids.0000076350.42412.a5.
216. Takebe, Y., Kusagawa, S., Motomura, K., Molecular epidemiology of HIV: tracking AIDS pandemic. Pediatr. Int. 46 (2004), 236–244, 10.1046/j.1442-200x.2004.01869.x.
217. Takebe, Y., Uenishi, R., Li, X., Global molecular epidemiology of HIV: understanding the genesis of AIDS pandemic. Adv. Pharmacol. 56 (2008), 1–25, 10.1016/S1054-3589(07)56001-1.
218. Takebe, Y., Liao, H., Hase, S., Uenishi, R., Li, Y., Li, X.-J., Han, X., Shang, H., Kamarulzaman, A., Yamamoto, N., Pybus, O.G., Tee, K.K., Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies. Vaccine 28:Suppl. 2 (2010), B39–B44, 10.1016/j.vaccine.2009.07.101.
219. Tee, K.K., Pon, C.K., Kamarulzaman, A., Ng, K.P., Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 19 (2005), 119–126.
220. Tee, K.K., Saw, T.L., Pon, C.K., Kamarulzaman, A., Ng, K.P., The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res. Hum. Retrovir. 21 (2005), 1046–1050, 10.1089/aid.2005.21.1046.
221. Tee, K.K., Li, X.-J., Nohtomi, K., Ng, K.P., Kamarulzaman, A., Takebe, Y., Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J. Acquir. Immune Defic. Syndr. 43 (2006), 523–529, 10.1097/01.qai.0000242451.74779.a7.
222. Tee, K.K., Pybus, O.G., Li, X.-J., Han, X., Shang, H., Kamarulzaman, A., Takebe, Y., Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J. Virol. 82 (2008), 9206–9215, 10.1128/JVI.00399-08.
223. The Antiretroviral Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372 (2008), 293–299, 10.1016/S0140-6736(08)61113-7.
224. Thomson, M.M., Najera, R., Increasing HIV-1 genetic diversity in Europe. J. Infect. Dis. 196 (2007), 1120–1124, 10.1086/521683.
225. Thomson, M.M., Delgado, E., Manjón, N., Ocampo, A., Villahermosa, M.L., Mariño, A., Herrero, I., Cuevas, M.T., Vázquez-de Parga, E., Pérez-Alvarez, L., Medrano, L., Taboada, J.A., Nájera, R., HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 15 (2001), 509–516.
226. Thomson, M.M., de Parga, E.V., Vinogradova, A., Sierra, M., Yakovlev, A., Rakhmanova, A., Delgado, E., Casado, G., Muñoz, M., Carmona, R., Vega, Y., Pérez-Alvarez, L., Contreras, G., Medrano, L., Osmanov, S., Nájera, R., New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses. AIDS Res. Hum. Retrovir. 23 (2007), 1599–1604, 10.1089/aid.2007.0166.
227. Tienen, C.v., van der Loeff, M.S., Zaman, S.M.A., Vincent, T., Sarge-Njie, R., Peterson, I., Leligdowicz, A., Jaye, A., Rowland-Jones, S., Aaby, P., Whittle, H., Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea–Bissau. J. Acquir. Immune Defic. Syndr. 53 (2010), 640–647, 10.1097/QAI.0b013e3181bf1a25.
228. Tovanabutra, S., Polonis, V., De Souza, M., Trichavaroj, R., Chanbancherd, P., Kim, B., Sanders-Buell, E., Nitayaphan, S., Brown, A., Robb, M.R., Birx, D.L., McCutchan, F.E., Carr, J.K., First CRF01_AE/B recombinant of HIV-1 is found in Thailand. AIDS 15 (2001), 1063–1065.
229. Tovanabutra, S., Watanaveeradej, V., Viputtikul, K., De Souza, M., Razak, M.H., Suriyanon, V., Jittiwutikarn, J., Sriplienchan, S., Nitayaphan, S., Benenson, M.W., Sirisopana, N., Renzullo, P.O., Brown, A.E., Robb, M.L., Beyrer, C., Celentano, D.D., McNeil, J.G., Birx, D.L., Carr, J.K., McCutchan, F.E., A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res. Hum. Retrovir. 19 (2003), 561–567, 10.1089/088922203322230923.
230. Tovanabutra, S., Beyrer, C., Sakkhachornphop, S., Razak, M.H., Ramos, G.L., Vongchak, T., Rungruengthanakit, K., Saokhieo, P., Tejafong, K., Kim, B., De Souza, M., Robb, M.L., Birx, D.L., Jittiwutikarn, J., Suriyanon, V., Celentano, D.D., McCutchan, F.E., The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res. Hum. Retrovir. 20 (2004), 465–475, 10.1089/088922204323087705.
231. Tovanabutra, S., Kijak, G.H., Beyrer, C., Gammon-Richardson, C., Sakkhachornphop, S., Vongchak, T., Jittiwutikarn, J., Razak, M.H., Sanders-Buell, E., Robb, M.L., Suriyanon, V., Birx, D.L., Michael, N.L., Celentano, D.D., McCutchan, F.E., Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. AIDS Res. Hum. Retrovir. 23 (2007), 829–833, 10.1089/aid.2006.0300.
232. Tripathy, S.P., Kulkarni, S.S., Jadhav, S.D., Agnihotri, K.D., Jere, A.J., Kurle, S.N., Bhattacharya, S.K., Singh, K., Tripathy, S.P., Paranjape, R.S., Subtype B and subtype C HIV type 1 recombinants in the northeastern state of Manipur, India. AIDS Res. Hum. Retroviruses 21 (2005), 152–157, 10.1089/aid.2005.21.152.
233. UNAIDS, AIDS by the Numbers, 2015. 2015 (Geneva, Switzerland).
234. UNAIDS, Global AIDS Update. 2016 (Geneva, Switzerland).
235. United Nations Office on Drugs and Crime (UNODC), World Drug Report. 2014 (Vienna, Austria).
236. Vallari, A., Bodelle, P., Ngansop, C., Makamche, F., Ndembi, N., Mbanya, D., Kaptué, L., Gürtler, L.G., McArthur, C.P., Devare, S.G., Brennan, C.A., Four new HIV-1 group N isolates from Cameroon: prevalence continues to be low. AIDS Res. Hum. Retrovir. 26 (2010), 109–115, 10.1089/aid.2009.0178.
237. Vallari, A., Holzmayer, V., Harris, B., Yamaguchi, J., Ngansop, C., Makamche, F., Mbanya, D., Kaptué, L., Ndembi, N., Gürtler, L., Devare, S., Brennan, C.A., Confirmation of putative HIV-1 group P in Cameroon. J. Virol. 85 (2011), 1403–1407, 10.1128/JVI.02005-10.
238. Van Heuverswyn, F., Li, Y., Neel, C., Bailes, E., Keele, B.F., Liu, W., Loul, S., Butel, C., Liegeois, F., Bienvenue, Y., Ngolle, E.M., Sharp, P.M., Shaw, G.M., Delaporte, E., Hahn, B.H., Peeters, M., Human immunodeficiency viruses: SIV infection in wild gorillas. Nature, 444, 2006, 164, 10.1038/444164a.
239. Vermund, S.H., Leigh-Brown, A.J., The HIV epidemic: high-income countries. Cold Spring Harb. Perspect. Med., 2, 2012, a007195, 10.1101/cshperspect.a007195.
240. Vongsheree, S., Phutiprawan, T., Sri-ngam, P., Thaisri, H., Puangtabtim, W., Sawanpanyalert, P., Co-existence of HIV-1 subtypes B’ and E infections among Thai injecting drug users. Asian Pac. J. Allergy Immunol. 20 (2002), 29–35.
241. Weber, R., Huber, M., Battegay, M., Stähelin, C., Castro Batanjer, E., Calmy, A., Bregenzer, A., Bernasconi, E., Schoeni-Affolter, F., Ledergerber, B., Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 16 (2015), 137–151, 10.1111/hiv.12184.
242. WHO, Consolidated Strategic Information Guidelines for HIV in the Health Sector. 2015, World Health Organization, Geneva, Switzerland.
243. WHO, UNAIDS, Guidelenes for Second Generation HIV Surveillance: An Update: Know Your Epidemic. 2013 (Geneva).
244. Wolfe, D., Carrieri, M.P., Shepard, D., Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 376 (2010), 355–366, 10.1016/S0140-6736(10)60832-X.
245. Wood, E., Hogg, R.S., Lima, V.D., Kerr, T., Yip, B., Marshall, B.D.L., Montaner, J.S.G., Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA 300 (2008), 550–554, 10.1001/jama.300.5.550.
246. Worobey, M., Gemmel, M., Teuwen, D.E., Haselkorn, T., Kunstman, K., Bunce, M., Muyembe, J.-J., Kabongo, J.-M.M., Kalengayi, R.M., Van Marck, E., Gilbert, M.T.P., Wolinsky, S.M., Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455 (2008), 661–664, 10.1038/nature07390.
247. Yerly, S., Jost, S., Monnat, M., Telenti, A., Cavassini, M., Chave, J.-P., Kaiser, L., Burgisser, P., Perrin, L., HIV-1 co/super-infection in intravenous drug users. AIDS 18 (2004), 1413–1421.
248. Yu, X.F., Chen, J., Shao, Y., Beyrer, C., Liu, B., Wang, Z., Liu, W., Yang, J., Liang, S., Viscidi, R.P., Gu, J., Gurri-Glass, G., Lai, S., Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J. Acquir. Immune Defic. Syndr. 22 (1999), 180–188.
249. Zarandia, M., Tsertsvadze, T., Carr, J.K., Nadai, Y., Sanchez, J.L., Nelson, A.K., HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. AIDS Res. Hum. Retrovir. 22 (2006), 470–476, 10.1089/aid.2006.22.470.
250. Zetterberg, V., Ustina, V., Liitsola, K., Zilmer, K., Kalikova, N., Sevastianova, K., Brummer-Korvenkontio, H., Leinikki, P., Salminen, M.O., Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res. Hum. Retrovir. 20 (2004), 1148–1156, 10.1089/aid.2004.20.1148.
251. Zheng, X., Tian, C., Choi, K.H., Zhang, J., Cheng, H., Yang, X., Li, D., Lin, J., Qu, S., Sun, X., Injecting drug use and HIV infection in southwest China. AIDS 8 (1994), 1141–1147.
252. Zhou, Y.-H., Liang, Y.-B., Pang, W., Qin, W.-H., Yao, Z.-H., Chen, X., Zhang, C., Zheng, Y.-T., Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission. BMC Infect. Dis., 14, 2014, 463, 10.1186/1471-2334-14-463.
253. Zhu, T., Korber, B.T., Nahmias, A.J., Hooper, E., Sharp, P.M., Ho, D.D., An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391 (1998), 594–597, 10.1038/35400.